Amanote Research

Amanote Research

    RegisterSign In

TALENs Targeting HBV: Designer Endonuclease Therapies for Viral Infections

Molecular Therapy - United States
doi 10.1038/mt.2013.208
Full Text
Open PDF
Abstract

Available in full text

Categories
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
Date

October 1, 2013

Authors
Nicholas D WeberDaniel StoneKeith R Jerome
Publisher

Elsevier BV


Related search

Antiviral Therapies for Respiratory Viral Infections in Lung Transplant Patients

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Designer Organoids for Modeling Epigenetics, Signaling, and Therapies in Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

In Vivo Disruption of Latent HSV by Designer Endonuclease Therapy

JCI insight
Medicine
2016English

Potential Application of TALENs Against Murine Cytomegalovirus Latent Infections

Viruses
VirologyInfectious Diseases
2019English

HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation

Journal of Clinical and Translational Hepatology
2018English

Myotonic Dystrophies: Targeting Therapies for Multisystem Disease

Neurotherapeutics
NeurologyPharmacology
2018English

Immunotherapy for Viral and Fungal Infections

Bone Marrow Transplantation
TransplantationHematology
2015English

Defensins in Viral Infections

Journal of Innate Immunity
AllergyImmunology
2009English

Viral-Specific T Lymphocytes for Treatment of Viral Infections in Primary Immunodeficiency

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy